SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
269 Some humor... laff till you drop Out of the Companys report ); ... .. IMPACT OApache Indian-2/18/1998
268 Company Report ..... ntii.comApache Indian-2/18/1998
267 Does anyone know of an instance in which a Biotech company with a promising pipJMarcus-2/13/1998
266 Where does ntii go from here? As one who has bet a good part of my farm (albeibtd-2/13/1998
265 To Dr. John and All: The Evening News - or is it news? Comments? Thoughts? NW_Trader-2/13/1998
264 John, A more pressing question for me is why no interest in memantine from bigJames Silverman-2/8/1998
263 >>>Please tell me what I'm missing here?<<<< John, IJohn Wright-2/7/1998
262 John, << NTII's patent position is strong and clear. Please tell meSam Quentin-2/6/1998
261 On paper you are correct that NTI has a $2MM market value. But, you need to empDr. John M. de Castro-2/6/1998
260 Apache, with a mkt cap of $2m I'm not sure NTII will find an individual invJohn Wright-2/6/1998
259 What a spread Bid 19/32 Ask 1 3/32 ! The beauty of OTC:BB... sure could use soApache Indian-2/5/1998
258 What was the closing stock price on Wednesday? I could not obtain a quote on YJMarcus-2/4/1998
257 "We are now in discussions with potential individual and institutional invlrb-2/4/1998
256 Ah, sh**. I was afraid of this. I really don't understand this. NASDAQ has John Dwyer-2/4/1998
255 Delisting RICHMOND, Calif., Feb. 3 /PRNewswire/ -- Neurobiological TechnologieDoug Markle-2/3/1998
254 Based on my understanding of the patents thing, if the company does not come ouApache Indian-2/2/1998
253 Response to patents question from IR -----------------------------------------Apache Indian-2/2/1998
252 Dr de Castro, They could make a deal depending on number of indications, with iCacaito-1/30/1998
251 Dear NeuroInvestment: Apache Indian asks a good question - "Somebody scarSam Quentin-1/30/1998
250 NTII doesn't have to cut a deal with a pharmaceutical company by tommorrow.Dr. John M. de Castro-1/29/1998
249 The fact that the Phase II Xerecept trial was initiated with the blessing of thDr. John M. de Castro-1/29/1998
248 It was in fact a p value of .10; i.e. a 10% statistical likelihood that the treNeuroInvestment-1/29/1998
247 Point taken (re:safety profile)... and nobody was expecting proven efficacy froPeter Silsbee-1/29/1998
246 Good news, and the type II is ongoing. I will look for the January, Annals of OCacaito-1/29/1998
245 "the potential to be at least as effective as the current standard treatmelrb-1/29/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News